NCT03832036View on ClinicalTrials.gov

The Diagnostic and Prognostic Value of Two Quantitative Clinical Tests in Patients With Lumbar Disc Herniation

NACompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

January 1, 2021

Study Completion Date

January 1, 2021

Conditions
PainLumbar Disc HerniationBack PainSpinal DiseasesSurgery
Interventions
DIAGNOSTIC_TEST

Paraspinal Mapping and Quantitative Sensory Pain Test

Participants will be tested at baseline.

Trial Locations (1)

2000

Center for Rheumatology and Spine Diseases, Frederiksberg Hospital., Frederiksberg

All Listed Sponsors
collaborator

Frederiksberg University Hospital

OTHER

collaborator

Center for Rheumatology and Spine Diseases, Frederiksberg Hospital, Denmark

UNKNOWN

collaborator

Odense University Hospital

OTHER

lead

Spine Centre of Southern Denmark

OTHER

NCT03832036 - The Diagnostic and Prognostic Value of Two Quantitative Clinical Tests in Patients With Lumbar Disc Herniation | Biotech Hunter | Biotech Hunter